Completion of Capital Raising & Issuance of Shares
Released
Released
Announcement PDF
Parkway Minerals NL
ASX
ACN 147 346 334
Announcement
23 October 2020
ASX:
FSE:
Level 1, 677 Murray Street
West Perth WA 6005
PO Box 174
West Perth WA 6872
Australia
T +61 8 9479 5386
parkwayminerals.com.au
PWN
4IP
COMPLETION OF CAPITAL RAISING
& ISSUANCE OF SHARES
Parkway Minerals NL (ASX: PWN) (“Parkway Minerals” or the “Company”) is pleased to
advise:
178,253,330 new fully paid ordinary shares relating to the placement announced on
19 October 2020, have now been issued.
4,185,877 new fully paid ordinary shares have also been issued under the Director &
Senior Management Fee & Remuneration Sacrifice Share Plan. Director and senior
management participation in the plan was adopted as a COVID-19 related cost-saving
measure and was disclosed at the time in the March 2020 Quarterly Report (16 April
2020).
1,800,000 new fully paid ordinary shares have also been issued in lieu of cash for
services provided by Spark+, a Singapore based corporate advisory firm, which has
assisted in introducing the Company to a range of strategic and institutional investors.
Change of Director’s Interest Notices, reflecting the respective increase in
shareholdings, are also attached.
On behalf of Parkway Minerals NL.
Bahay Ozcakmak
Managing Director
T: +61 414 596 007
E: bahay@parkwayminerals.com.au
aMES™ Technology
The activated Mineral Extraction System, or aMES™
is an innovative process technology that enables the
treatment of concentrated brine solutions to recover a
range of valuable compounds, reagents and fresh
water. The technology utilises a proprietary multistaged process incorporating novel membrane
technology and is based on proprietary IP,
incorporating patents, expertise and know-how
acquired over more than a decade of intense process
development.
Advantages of the aMES™ technology include:
improvements in mineral recovery and
product quality,
opportunity for substantial project capex &
opex savings,
efficient use of energy and produces pure
water as a by-product, and
improved project footprint and environmental
sustainability.
Ongoing collaboration with a number of brine project
developers and operators has confirmed there are
many applications where the aMES™ technology has
the potential to deliver substantial value by enhancing
existing flowsheets, in order to improve overall project
performance.
aMES™
Brine Processing Technology
Key Industries (Applications)
Mining natural brine (salt lakes)
Solution mining brine (potash)
Refinery & industrial waste brine
Wastewater treatment brine
Target Products (Produced)
Potash (MOP/SOP/KMS)
Lithium and magnesium salts
Range of byproducts (B, Br, Ca,
Co, Cu, I, Na, Ni, REE, Si, Sr)
Reagents
Water
Additional Information
www.parkwayminerals.com.au/ames-technology
iBC™ Technology
The integrated Brine Causticization, or iBC™ is a
patented process technology that simultaneously
removes common impurities from waste brine streams
and converts sodium carbonates and bicarbonates
commonly found in coal seam gas (CSG) brines, into
more soluble sodium hydroxide.
As a result of the causticization step, the iBC™
technology produces a purified brine suitable for
downstream processing, including with the aMES™
technology, for the production of various salt products
and industrial-grade sodium hydroxide.
iBC™
Brine Pre-Treatment Technology
Key Industries (Applications)
Oil & gas waste brine (CSG)
Wastewater treatment brine
Target Products (Produced)
Sodium hydroxide concentrate
Additional Information
Sodium chloride
https://www.parkwayminerals.com.au/ibc-technology
Byproducts (Ca, Mg, Si)
23 October 2020
|
ASX Announcement
| 2
About Parkway Minerals
In October 2019, Parkway Minerals (ASX: PWN) completed a transformational transaction by acquiring
an Australian unlisted public company, Consolidated Potash Corporation (CPC). Through CPC,
Parkway Minerals acquired a minority interest in the Karinga Lakes Potash Project (KLPP) in NT
Australia, as well as a majority interest in the New Mexico Lithium Project (NMLP), in the United States.
The CPC transaction, also resulted in Parkway Minerals acquiring the innovative aMES™ technology,
which has been developed to process a range of challenging brine streams from the mining industry,
in order to recover valuable minerals, reagents as well as produce fresh water.
Given the significant market opportunities, Parkway Minerals is focused on commercialising a worldclass technology portfolio to provide long-term sustainable solutions for processing complex brines, in
the energy, mining and wastewater industries. In order to achieve this objective, Parkway Minerals is
partnering with leading industry participants to provide, BPaaS – Brine Processing as a Solution™.
Strategic Investment
Parkway Minerals holds a strategic investment in Davenport Resources (ASX: DAV), which has
successfully delineated a globally significant in-situ potash resource (in excess of 550 million tonnes of
contained potash), at its South Harz project in Central Germany. Recently completed scoping studies
have delivered excellent technical and economic results and provide Davenport Resources with an
attractive opportunity to create and unlock substantial value.
Parkway Minerals is commercialising a world-class technology portfolio to provide long-term
sustainable solutions for processing complex brines, in the energy, mining and wastewater
industries.
Our mission is to collaborate with leading strategic partners to deliver:
BPaaS – Brine Processing as a Solution™.
Forward-Looking Statements
This ASX Release may contain certain “forward-looking statements” which may be based on forward-looking information that are
subject to a number of known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially
from those presented here. Where the Company expresses or implies an expectation or belief as to future events or results, such
expectation or belief is expressed in good faith and believed to have a reasonable basis. Forward-looking information includes
exchange rates; proposed or projected project or transaction timelines; uncertainties and risks associated with the advantages
and/or performance of the Company’s projects and/or technologies; uncertainties and risks regarding the estimated capital and
operating costs; uncertainties and risks regarding any envisaged timelines in relations to any results, milestones, partnerships,
including but not limited to any milestones which may require obtaining approvals from third parties.
For a more detailed discussion of such risks and other factors, see the Company’s other ASX Releases. Readers should not
place undue reliance on forward-looking information. The Company does not undertake any obligation to release publicly any
revisions to any forward-looking statement to reflect events or circumstances after the date of this ASX Release, or to reflect the
occurrence of unanticipated events, except as may be required under applicable securities laws.
23 October 2020
|
ASX Announcement
| 3
Share your feedback
Discover